Core Viewpoint - Chao Yan Co., Ltd. has shown a stable financial performance with a notable increase in revenue and net profit, while also experiencing changes in shareholder structure and trading activity [1][2][3]. Financial Performance - For the first half of 2025, Chao Yan Co., Ltd. achieved operating revenue of 184 million yuan, representing a year-on-year growth of 15% [2]. - The net profit attributable to shareholders reached 68.45 million yuan, marking an 18.5% increase compared to the previous period [2]. Shareholder Structure - As of June 30, 2025, the number of shareholders decreased by 16.65% to 22,300, while the average circulating shares per person increased by 19.98% to 2,456 shares [2]. - The top circulating shareholder is Huabao Zhongzheng Medical ETF, holding 1.91 million shares as a new shareholder [3]. - Other notable new shareholders include Southern Zhongzheng 1000 ETF and Huaxia Zhongzheng 1000 ETF, indicating a shift in institutional holdings [3]. Trading Activity - On October 27, 2023, Chao Yan Co., Ltd. experienced a slight decline of 0.36% in stock price, with a trading volume of 50.21 million yuan [1]. - The financing buy-in amount for the day was 7.87 million yuan, with a net buy of 5.14 million yuan after repayments [1]. - The total margin trading balance reached 97.31 million yuan, with financing accounting for 6.68% of the circulating market value [1].
超研股份10月27日获融资买入787.19万元，融资余额9711.50万元